Publications

Correspondence on "Parents' perceptions of the utility of genetic testing in the NICU" by Callahan et al.

Genet Med
Sansom SL, Mighton C, Smith HS.

Determining the value of genomics in healthcare.

Nat Med
Goranitis I, Hayeems RZ, Smith HS, Buchanan J, Weymann D, Regier DA, Mackley MP, Scott RH, Hill SL, Chung BHY, Chung CCY, Best S, Baple EL, Stark Z.

Determining the value of genomics in healthcare

Nat Med.
Goranitis I, Hayeems RZ, Smith HS, Buchanan J, Weymann D, Regier DA, Mackley MP, Scott RH, Hill SL, Chung BHY, Chung CCY, Best S, Baple EL, Stark Z

A Lack of Information About Family Health History Motivates Adopted Individuals to Pursue Elective Genomic Testing

Am J Med Genet A.
Hickingbotham MR, Bell M, Zoltick ES, Platt D, Leonhard JR, Hajek C, Green RC, Smith HS, Christensen KD.

Data-Related and Methodological Challenges in Assessing the Cost-Effectiveness of Traditional and Genomic Newborn Screening Programs

Appl Health Econ Health Policy
Lamsal R, Smith HS, Grosse SD.

An end to genetic exceptionalism: reframing the ethics of genomic sequencing for rapid neonatal diagnosis.

Semin Perinatol
Shulman KS, Fishler Malone K, Smith HS, Chaudhari BP, Wojcik MH.

Facing the Next Generation of US Newborn Screening

JAMA Pediatrics
Smith HS, Motta MP

Facing the Next Generation of US Newborn Screening.

JAMA Pediatr
Smith HS, Motta MP.

Evidence Regarding Duchenne Muscular Dystrophy Newborn Screening.

Pediatrics
Kemper AR, Lam WKK, Ojodu J, Jones E, Smith HS, Comeau AM, Tanksley S, Ream MA, Grosse SD.

Evidence Regarding Metachromatic Leukodystrophy Newborn Screening

Pediatrics
Lam WKK, Ream MA, Grosse SD, Ojodu J, Jones E, Smith HS, Comeau AM, Tanksley S, Kemper AR

Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.

Value Health
Smith HS, Buchanan J, Goranitis I, IJzerman MJ, Lavelle TA, Marshall DA, Regier DA, Ungar WJ, Weymann D, Wordsworth S, Phillips KA, Jansen JP.

When families bridge the research-clinical divide: An exploration of values regarding cascade screening in genomic research

Genetics in Medicine Open
Bonini KE, Desrosiers-Battu LR, Foreman AKM, Sahin-Hodoglugil NN, Majumder MA, Finnila CR, Kraft SA, Amendola LM, Kenny EE, Fullerton SM, Ackerman SL, Wilfond BS, McGuire AL, Smith HS

An end to genetic exceptionalism: reframing the ethics of genomic sequencing for rapid neonatal diagnosis

Semin Perinatol
Shulman KS, Fishler Malone K, Smith HS, Chaudhari BP, Wojcik MH

Preferences for genetic testing among populations underrepresented in genomic research: a systematic review.

Eur J Hum Genet
Montgomery T, Hickingbotham MR, Smith HS.

Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework.

Appl Health Econ Health Policy
Smith HS, Regier DA, Goranitis I, Bourke M, IJzerman MJ, Degeling K, Montgomery T, Phillips KA, Wordsworth S, Buchanan J, Marshall DA

Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data.

Appl Health Econ Health Policy
Smith HS, Lakoma M, Hickingbotham MR, Cardeiro D, Callahan KP, Wojcik MH, Wu AC, Lu CY

When families bridge the research-clinical divide: An exploration of values regarding cascade screening in genomic research.

Genet Med Open
Bonini KE, Desrosiers-Battu LR, Foreman AKM, Sahin-Hodoglugil NN, Majumder MA, Finnila CR, Kraft SA, Amendola LM, Kenny EE, Fullerton SM, Ackerman SL, Wilfond BS, McGuire AL, Smith HS.

Rare disease narratives on social media: A content analysis.

Genet Med Open
Park HJ, Scott CJ, Smith HS, Wojcik MH.

Family Genetic Risk Communication and Reverse Cascade Testing in the BabySeq Project.

Genet Med
Uveges MK, Smith HS, Pereira S, Genetti C, McGuire AL, Beggs AH, Green RC, Holm IA,

Where the Genetic Code Meets the Zip Code: Advancing Equity in Rare Disease Genomics.

Hastings Cent Rep
Wojcik MH, Smith HS, Fraiman YS